Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | CA2 | P00918 | 6/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10990502 | 0.83 | ALDH1A1 (0.52) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4281881 | 0.82 | ALDH1A1 (0.62) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL1873149 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4274177 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL16594856 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4652969 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4269643 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4654331 | 0.79 | ALDH1A1 (0.59) | ALDH1A1TDP1CYP3A4TSHRCA2 | |
| SCHEMBL4392795 | 0.79 | — | — | |
| SCHEMBL17968544 | 0.79 | CA2 (0.44) | ALDH1A1TDP1CYP3A4TSHRCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11008343-B2 | Heterocyclic compound and organic electronic device comprising same | LG CHEM, LTD. | 2021-05-18 | — | — | US | disclosed |
| EP-3473627-B1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEMICAL LTD (KR) | 2020-03-18 | — | — | EP | disclosed |
| US-20190284210-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-09-19 | — | — | US | disclosed |
| EP-3473627-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190284210-A1 | HETEROCYCLIC COMPOUND AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME | CYP1A1, CYP1B1, ODC1 | ALDH1A1 75/4885TDP1 2395/4885CYP3A4 23/4885 |
| US-11008343-B2 | Heterocyclic compound and organic electronic device comprising same | CYP1A1, CYP1B1, ODC1 | ALDH1A1 75/4885TDP1 2395/4885CYP3A4 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.